This article has been updated to include a response from Med BioGene.
NEW YORK (GenomeWeb News) – Signal Genetics has made what it said is a "superior offer" to license Med BioGene's LungExpress Dx technology.
This article has been updated to include a response from Med BioGene.
NEW YORK (GenomeWeb News) – Signal Genetics has made what it said is a "superior offer" to license Med BioGene's LungExpress Dx technology.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.